Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial looked at calprotectin and ischemia modified albumin as blood markers for Behçet's disease activity — are either of these markers something you currently measure in my care, or could they be useful for tracking how active my disease is?
2. 2The trial used something called the Behçet's Disease Current Activity Form to measure disease activity — is that scoring tool something you use in my case, and how do you currently decide whether my Behçet's is active or in remission?
3. 3Since this study is already completed, have the results been published yet, and if so, do they suggest these blood tests could eventually replace or supplement the way disease activity is monitored in patients like me?
4. 4Could measuring calprotectin or ischemia modified albumin in my blood give you earlier or more objective signals of a flare compared to what we're relying on now, and is that worth discussing as part of my ongoing monitoring plan?
5. 5Are there other research studies or clinical tools building on this kind of biomarker work for Behçet's disease that might be relevant to my situation, given that this trial has already wrapped up?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.